04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The State of Illinois has enacted new laws and amendments that create new requirements and obligatio...
Read More >
Resort implemented strict rules forbidding Spanish and retaliated against workers when they complain...
Read More >
Corporate compliance officers always welcome the new year with a string of new regulatory compliance...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
On June 19th, the New York State Senate and Assembly voted to pass omnibus legislation greatly stren...
Read More >
As reported previously, in March of 2018, the UK Department of Work and Pensions issued a white pape...
Read More >